Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activity
Z. Yuan, G. Syrkin, A. Adem, R. Geha, J. Pastoriza, C. Vrikshajanani, T. Smith, T. J. Quinn, G. Alemu, H. Cho, C. J. Barrett, W. Arap, R. Pasqualini, S. K. Libutti
Dive into the research topics of 'Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activity'. Together they form a unique fingerprint.